Cutler v. Hayes OTC drug review challenge dismissed.
This article was originally published in The Tan Sheet
Executive Summary
CUTLER v. HAYES OTC DRUG REVIEW CHALLENGE DISMISSED Sept. 6 by Washington, D.C. District Court Judge Thomas Penfield Jackson, FDA announced Sept. 13. The suit, which took issue with several aspects of the OTC drug review program, was dismissed from the bench, with prejudice, following a "presentation by the government on the accomplishments and current status of the review," FDA said.